These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 9891864

  • 21. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z, Chen SJ, Wang ZY.
    C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
    [Abstract] [Full Text] [Related]

  • 22. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group.
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [Abstract] [Full Text] [Related]

  • 23. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.
    Nature; 1998 Feb 19; 391(6669):815-8. PubMed ID: 9486655
    [Abstract] [Full Text] [Related]

  • 24. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
    Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K.
    Blood; 1998 Jul 15; 92(2):374-82. PubMed ID: 9657734
    [Abstract] [Full Text] [Related]

  • 25. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
    Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P.
    Blood; 1998 Sep 01; 92(5):1758-67. PubMed ID: 9716606
    [Abstract] [Full Text] [Related]

  • 26. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
    Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara FF, Bonci D, Grignani F, Nervi C, Pelicci PG.
    Oncogene; 1999 Nov 04; 18(46):6313-21. PubMed ID: 10597230
    [Abstract] [Full Text] [Related]

  • 27. The molecular genetics of acute promyelocytic leukemia.
    Grignani F, Fagioli M, Ferrucci PF, Alcalay M, Pelicci PG.
    Blood Rev; 1993 Jun 04; 7(2):87-93. PubMed ID: 8396481
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L, Levin AA, Scicchitano BM, Grignani F, Allenby G, Diverio D, Lo Coco F, Avvisati G, Ruthardt M, Adamo S, Pelicci PG, Nervi C.
    Blood; 1997 Aug 01; 90(3):1175-85. PubMed ID: 9242550
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [A study on the relationship between morphology and gene heterogeneity in acute promyelocytic leukemia].
    Xiong S, Chen Z, Huang W.
    Zhonghua Nei Ke Za Zhi; 1995 Mar 01; 34(3):165-8. PubMed ID: 7648936
    [Abstract] [Full Text] [Related]

  • 33. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP.
    Blood; 1996 Nov 15; 88(10):3926-36. PubMed ID: 8916959
    [Abstract] [Full Text] [Related]

  • 34. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E.
    Leukemia; 1996 Jan 15; 10(1):61-6. PubMed ID: 8558940
    [Abstract] [Full Text] [Related]

  • 35. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
    Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH.
    Blood; 1995 Aug 15; 86(4):1540-7. PubMed ID: 7632962
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.
    Pandolfi PP.
    Haematologica; 1996 Aug 15; 81(5):472-82. PubMed ID: 8952164
    [Abstract] [Full Text] [Related]

  • 38. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain.
    Sitterlin D, Tiollais P, Transy C.
    Oncogene; 1997 Mar 06; 14(9):1067-74. PubMed ID: 9070655
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F.
    Oncogene; 1994 Feb 06; 9(2):545-51. PubMed ID: 8290265
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.